Sale!

ASCA Anti Saccharomyces Cerevisiae Antibody Panel IgA and IgG Test Cost

Original price was: 650 د.إ.Current price is: 590 د.إ.

-9%

The ASCA (Anti-Saccharomyces Cerevisiae Antibody) Panel IgA and IgG Test is a specialized diagnostic tool used to aid in the diagnosis of certain inflammatory bowel diseases (IBD), such as Crohn’s disease. This test measures the levels of IgA and IgG antibodies against Saccharomyces cerevisiae, a type of yeast, in the blood. The presence of these antibodies can indicate an immune response associated with Crohn’s disease, although not exclusively.

DNA Labs UAE offers this comprehensive test for patients suspected of having or being monitored for Crohn’s disease. By assessing both IgA and IgG antibodies, the test provides a more complete picture of the immune response, potentially leading to a more accurate diagnosis. The cost of the ASCA Panel IgA and IgG Test at DNA Labs UAE is 590 AED.

The test is performed in a clinical laboratory setting, where a blood sample is collected from the patient and analyzed for the presence of these specific antibodies. Results from the ASCA test, in conjunction with other clinical findings and diagnostic tests, can help healthcare providers make informed decisions about the diagnosis, treatment, and management of inflammatory bowel diseases.

Patients interested in undergoing the ASCA Anti Saccharomyces Cerevisiae Antibody Panel IgA and IgG Test at DNA Labs UAE should consult with their healthcare provider to understand how this test fits into their overall diagnostic and treatment plan.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

ASCA ANTI SACCHAROMYCES CEREVISIAE ANTIBODY PANEL IgA and IgG Test

Price: 590.0 AED

Sample Condition: 2 mL (1 mL min.) serum from 1 SST. Ship refrigerated or frozen.

Report Delivery: SampleThu by 9 am; Report Same day

Method: Enzyme Immunoassay

Test Type: Disorders of Gastrointestinal Tract

Doctor: Gastroenterologist

Test Department:

Pre Test Information: No special preparation required

Test Details

The ASCA (Anti-Saccharomyces cerevisiae antibody) panel is a blood test that measures the levels of IgA and IgG antibodies against Saccharomyces cerevisiae, a type of yeast. This test is primarily used in the diagnosis and management of inflammatory bowel disease (IBD), particularly Crohn’s disease.

Approximately 60-70% of patients with Crohn’s disease have been found to have elevated levels of ASCA antibodies. The test involves drawing a blood sample from the patient, which is then sent to a laboratory for analysis. The levels of IgA and IgG antibodies against Saccharomyces cerevisiae are measured using specific techniques, such as enzyme-linked immunosorbent assay (ELISA).

Elevated levels of ASCA antibodies, particularly IgG, can help support a diagnosis of Crohn’s disease, especially in patients with unclear symptoms or when other diagnostic tests are inconclusive. However, it is important to note that the presence of ASCA antibodies alone is not sufficient to diagnose Crohn’s disease, as some healthy individuals and patients with other conditions may also have elevated levels.

The ASCA panel test is typically ordered by a gastroenterologist or other healthcare provider specializing in IBD. The results of the test, along with other clinical findings and diagnostic tests, are used to aid in the diagnosis and management of Crohn’s disease.

Test Name ASCA ANTI SACCHAROMYCES CEREVISIAE ANTIBODY PANEL IgA and IgG Test
Components
Price 590.0 AED
Sample Condition 2 mL (1 mL min.) serum from 1 SST. Ship refrigerated or frozen.
Report Delivery SampleThu by 9 am; Report Same day
Method Enzyme Immunoassay
Test type Disorders of Gastrointestinal Tract
Doctor Gastroenterologist
Test Department:
Pre Test Information No special preparation required
Test Details

The ASCA (Anti-Saccharomyces cerevisiae antibody) panel is a blood test that measures the levels of IgA and IgG antibodies against Saccharomyces cerevisiae, a type of yeast.

This test is primarily used in the diagnosis and management of inflammatory bowel disease (IBD), particularly Crohn’s disease. Approximately 60-70% of patients with Crohn’s disease have been found to have elevated levels of ASCA antibodies.

The test involves drawing a blood sample from the patient, which is then sent to a laboratory for analysis. The levels of IgA and IgG antibodies against Saccharomyces cerevisiae are measured using specific techniques, such as enzyme-linked immunosorbent assay (ELISA).

Elevated levels of ASCA antibodies, particularly IgG, can help support a diagnosis of Crohn’s disease, especially in patients with unclear symptoms or when other diagnostic tests are inconclusive. However, it is important to note that the presence of ASCA antibodies alone is not sufficient to diagnose Crohn’s disease, as some healthy individuals and patients with other conditions may also have elevated levels.

The ASCA panel test is typically ordered by a gastroenterologist or other healthcare provider specializing in IBD. The results of the test, along with other clinical findings and diagnostic tests, are used to aid in the diagnosis and management of Crohn’s disease.